期刊文献+

抑癌基因PTEN在胃癌中的表达及临床意义 被引量:1

Expression and clinical significance of anti-oncogene PTEN in gastric carcinoma
下载PDF
导出
摘要 目的探讨胃癌组织中PTEN基因表达与胃癌临床病理的关系及其对预后的判断价值。方法应用免疫组化SP技术和图像分析技术,研究PTEN在胃癌和正常胃黏膜组织中的表达情况及阳性表达面积、强阳性表达面积,分析与病理参数的关系,并采用Kaplan-Meier生存曲线分析不同表达水平对术后生存率的影响。结果发现胃癌组织PTEN表达阳性率、阳性面积、强阳性面积均明显低于正常胃黏膜组织(P<0.01)。胃癌组织PTEN表达与胃癌组织分化程度、浸润深度、淋巴转移、肿瘤分期明显相关,术后3、5 a生存率低表达者明显低于高表达者(P均<0.05)。结论PTEN基因表达低下或丢失与胃癌发生、浸润、转移有关,可作为预测术后生存率的指标。 [ Objective] To study expression of anti-oncogene phosphatase and tensin homolog deleted on chromosome ten (PTEN) and its clinical significance in gastric carcinoma pathology and prognosis. [ Methods] SP immunohistochemistry and image analysis were used for studying the gene expression, positive expression area and strong positive expression area of PTEN in gastric carcinoma tissue and normal gastric mucosa tissue. The influence of postoperative survival rates in different expression level was analyzed with Kaplan-Meier survival curves. [ Results] Positive percentage, positive expression area and strong positive expression area of PTEN expression in gastric carcinoma tissue were much higher than those in normal gastric mucosa tissue ( P 〈0. 01 ). Expression of PTEN in gastric carcinoma tissue was related to differentiation degree, infiltration depth, lymphatic metastasis and tumor stage in gastric carcinoma tissue obviously. As for postoperative survival rates for 3 and 5 years, it was obviously that the hypo-expressers were lower than hyper-expressers. [ Conclusion] Decreased or lost expression of anti-oncogene PTEN correlates with occurrence, infiltration and metastasis in gastric carcinoma, and it can be used as a prognosis indication for of postoperative survival rates.
作者 梅新华
机构地区 临沂市人民医院
出处 《山东医药》 CAS 北大核心 2007年第19期50-52,共3页 Shandong Medical Journal
关键词 胃肿瘤 基因 肿瘤抑制 基因 PTEN 病理学 临床 存活率 stomach neoplasms genes, tumor suppressor gene, phosphatase and tensin homolog deleted on chromosome ten pathology, clinical survival rate
  • 相关文献

参考文献3

二级参考文献51

  • 1[1]Steck PA, Pershouse MA, Jasser SA, Yung WK, Lin H, Ligon AH,Langford LA, Baumgard ML, Hattier T, Davis T, Frye C, Hu R,Swedlund B, Teng DH, Tavtigian SV. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 1997; 15:356-362
  • 2[2]Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J,Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC,Ittmarn M, Tycko B, Hibshoosh H, Wigler MH, Parsons R. PTEN,a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 1997; 275:1943-1947
  • 3[3]Li DM, Sun H. TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta. Cancer Res 1997; 57:2124-2129
  • 4[4]Cantley LC, Neel BG.New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc Natl Acad Sci U S A 1999; 96: 4240-4245
  • 5[5]Wu X, Senechal K, Neshat MS, Whang YE, Sawyers CL. The PTEN/MMAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase/Akt pathway. Proc Natl Acad Sci U S A 1998; 95:15587-15591
  • 6[6]Sun H, Lesche R, Li DM, Liliental J, Zhang H, Gao J, Gavrilova N, Mueller B, Liu X, Wu H. PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,trisphosphate and Akt/protein kinase B signaling pathway.Proc Natl Acad Sci U S A 1999; 96:6199-6204
  • 7[7]Maehama T, Taylor GS, Dixon JE. PTEN and myotubularin: novel phosphoinositide phosphatases.Annu Rev Biochem 2001; 70: 247-279
  • 8[8]Besson A, Robbins SM, Yong VW. PTEN/MMAC1/TEP1 in signal transduction and tumorigenesis. Eur J Biochem 1999; 263: 605-611
  • 9[9]Waite KA, Eng C. Protean PTEN: form and function. Am J Hum Genet 2002; 70:829-844
  • 10[10]Tanno S, Tanno S, Mitsuuchi Y, Altomare DA, Xiao GH, Testa JR. AKT activation up-regulates insulin-like growth factor I receptor expression and promotes invasiveness of human pancreatic cancer cells. Cancer Res 2001; 61:589-593

共引文献136

同被引文献4

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部